Operator of an oncology company advancing precision medicine for cancer patients. Partnering with healthcare systems, it enables rapid genomic sequencing of biopsies, providing oncologists with tumor profiles and matched therapies within days for more informed treatment decisions.
Founded: 2015
Dan Rhodes, PhD Co-Founder & Chief Executive Officer |
Scott Tomlins, MD, PhD Co-Founder & Chief Medical Officer |
Matt Martin Chief Financial Officer |